English
Home > Products > Lornoxicam API

China Lornoxicam API Factory

Our company puts emphasis about the administration, the introduction of talented staff, along with the construction of employees building, seeking hard to boost the standard and liability consciousness of staff members members. Our business successfully attained IS9001 Certification and European CE Certification of Lornoxicam API,CAS NO 70374-39-9,70374-39-9,Lornoxicam, We are going to wholeheartedly welcome all clientele during the industry both of those at your home and overseas to cooperate hand in hand, and build a bright potential together.
Lornoxicam API, Wide selection and fast delivery to suit your needs! Our philosophy: Good quality, great service, keep improving. We are looking forward that more and more oversea friends join in our family for further development near the future!

Related Products

Hot Products

  • Felodipine

    Felodipine

    Product Name:Felodipine
    Molecular Formula:C18H19Cl2NO4
    Molecular Weight;384.25
    CAS Registry Number;72509-76-3/86189-69-7
  • Mertansine

    Mertansine

    Product Name:Mertansine
    Molecular Formula:C35H48ClN3O10S
    Molecular Weight:738.29
    CAS Registry Number:139504-50-0
  • Triptorelin

    Triptorelin

    Product Name:Triptorelin
    Molecular Formula:C64H82N18O13
    Molecular Weight;1311.45
    CAS Registry Number;57773-63-4
  • N-Propylacrylamide

    N-Propylacrylamide

    Product Name:N-Propylacrylamide
    Molecular Formula:C6H11NO
    Molecular Weight:113.16
    CAS Registry Number:25999-13-7
  • 4-(2-Fluorophenyl)-1H-Pyrrole-3-Carbonitrile

    4-(2-Fluorophenyl)-1H-Pyrrole-3-Carbonitrile

    Product Name:4-(2-Fluorophenyl)-1H-Pyrrole-3-Carbonitrile
    Molecular Formula:C11H7FN2
    Molecular Weight:186.19
    CAS Registry Number:103418-03-7
  • 2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide

    2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide

    Product Name:2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide
    Molecular Formula:C26H43BrO9
    Molecular Weight:579.53
    CAS Registry Number:81058-27-7
  • Related Blog
  • Reviews

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept